updated graphical abstract.pdf (583.1 kB)
Risk of Stroke in Real-World US Individuals with Type 2 Diabetes Receiving Semaglutide or a Dipeptidyl Peptidase-4 Inhibitor
Version 2 2024-02-12, 09:48
Version 1 2023-12-19, 10:59
media
posted on 2023-12-19, 10:59 authored by Adis Journals on Behalf of, Marc Evans, Mansoor Husain, Ayush Srivastava, Kamal Kant Mangla, Anja Birk Kuhlman, Ildiko Lingvay
Article full text
The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.
The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite).
